Hypersensitivity reaction management addresses immediate or delayed allergic responses enabling continued therapeutic use. Premedication regimens including antihistamines reduce severity. Slower infusion rates decrease anaphylaxis risk. Desensitisation protocols gradually escalate doses enabling treatment. Rechallenge strategies test whether previous reactions recur.
Alternative drugs without cross-reactivity enable therapy continuation. Diagnostic testing identifies causal allergens. Biomarker assessment predicts anaphylaxis risk. Patient counselling emphasises symptom reporting. Regulatory submissions incorporate hypersensitivity management guidance.
General Biopharmaceutical Concepts
Hypersensitivity Reaction Management
Hypersensitivity reaction management comprises strategies to prevent, recognise and treat immune-mediated allergic reactions associated with medicines or biological products.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →